Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.

Recent Press Releases

October 26, 2017 - 4:04 p.m.
Gilead Sciences Announces Fourth Quarter 2017 DividendPrinter Friendly Version 
October 26, 2017 - 4:02 p.m.
Gilead Sciences Announces Third Quarter 2017 Financial ResultsPrinter Friendly Version 

Upcoming Events

Saturday, December 9, 2017 through Tuesday, December 12, 2017
59th ASH Annual Meeting & Exposition
LocationAtlanta, GA

Most Viewed Links

Updated 11/21/17
1.SEC Filings
2.Annual Reports
3.Earnings
4.Stock Information
5.Fundamentals - Snapshot
* Data collected 11/13/17 - 11/20/17

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
NASDAQ (US Dollar)
$72.13
 Stock is Down 0.31 (0.43%)
Data as of 11/20/17 4:00 p.m. ET
Minimum 20 minute delay
Refresh Quote
Recent Webcasts
Gilead Sciences at Morgan Stanley Global Healthcare Conference

September 11, 2017 9:55 a.m. ET
Play
Gilead Sciences at Citi’s 12th Annual Biotech Conference

September 06, 2017 11:00 a.m. ET
Play
Gilead Sciences Business Update

August 28, 2017 8:00 a.m. ET
Play